Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Energy: early-phase trial registry

2 of 8 indexed Energy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Energy: 8 US clinical trials tracked, 2 recruiting.

Energy is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Iovate Health Sciences International, running 1 of these trials.

Enrollment posture brief

Registry condition energy

OPEN 2 | RECR 25% | LATE 0 | EARLY 1 | RANK #2176 | SPON 1

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Energy (this)25%
Open-enrollment share among volume-matched conditions near Energy

Energy lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Energy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Energy is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Energy trials is spread across many organizations.

    Iovate Health Sciences International accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Energy trials plan to enrol fewer than 100 people.

    Median target enrolment is 68 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.

  4. Energy research is mostly interventional.

    7 interventional and 1 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Energy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Other
2 trials
Paraxanthine 300 mg Other
1 trials
Paraxanthine 200 mg Other
1 trials
proprietary pre-workout supplement Dietary supplement
1 trials
Snack Product Other
1 trials
Energy Active Study Product 2.1 Usage Dietary supplement
1 trials
Energy Placebo Control Form 2 Dietary supplement
1 trials
Energy Active Study Product 1.2 Usage Dietary supplement
1 trials

US sites by state

Facility locations filed on Energy trials. A trial with sites in several states counts in each.

California 2 trials
Texas 1 trials
Ohio 1 trials
New York 1 trials
Louisiana 1 trials
Georgia 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Energy page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Energy condition card totals 8 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.